Chromosomal assignment of the human immunophilin FKBP-12 gene

Chromosomal assignment of the human immunophilin FKBP-12 gene

Vol. 179, No. 3, 1991 September 30, 1991 AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 1427-l 433 BIOCHEMICAL CHROMOSOMAL ASSIGNMENT OF THE HUMAN...

1MB Sizes 0 Downloads 60 Views

Vol. 179, No. 3, 1991 September 30, 1991

AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 1427-l 433

BIOCHEMICAL

CHROMOSOMAL

ASSIGNMENT

OF THE HUMAN IMMUNOPHILIN

FKBP-12 GENE

Anthony G. DiLella Department SmithKline

of Molecular Genetics

Beecham Pharmaceuticals

King of Prussia, PA 19406 Received

August

9, 1991

SUMMARY: FKBP-12 is the major T cell binding protein for the immunosuppressive drugs FK506 and rapamycin. It is a member of the immunophilin family of proteins which are believed to play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. The chromosomal assignment of the human FKBP-12 gene was determined by using the polymerase chain reaction to amplify an intron-containing region of the gene in purified DNA isolated from 42 human-rodent somatic cell hybrids. The results of this analysis indicated that the FKBP-12 gene resides on human chromosome 20. 0 1991AcademicPress, Inc.

The immunophilins identified

(immunosuppressant

as a family of proteins that catalyze the interconversion

rotamers of the peptidyl-prolyl in ref. 1). lmmunophilins FK506,

binding proteins)

rapamycin,

proteins. cyclosporin

of the cis- and trans-

amide bond of peptide and protein substrates (reviewed

are the cytosolic receptors for the immunosuppressive

and cyclosporin

A, which inhibit the rotamase

The major FK506-binding A-binding

have recently been

T cell immunophilin

T cell immunophilin

is cyclophilin

activity of these

is FKBP-12

(2) and the

(3). Following binding to their

specific cytoplasmic

receptors, both FK506 and cyclosporin A can independently

the T cell receptor

signal transmission

expression

of the same set of lymphokine

related to FK506, also specifically

conserved

are also distributed

(6,7), suggesting

addition to immunoregulation.

of T cell activation

genes (4). Rapamycin,

binds to FKBP-12

cell activation by blocking the lymphokine lmmunophilins

pathway

in non-lymphoid

by inhibiting

a drug structurally

pathway (4,5).

cells and are phylogenetically

play a role in cellular

However, the endogenous

are not known; the biological significance

of immunophilin

processes

in

ligands of the immunophilins rotamase activity within cells 0006-291X/91

1427

block

(2) but inhibits a later stage of T

receptor signal transmission

that these proteins

drugs

$1.50

Copyright 0 1991 by Academic Press, Inc. All rights of reproduction in any form reserved.

Vol. 179, No. 3, 1991

BlOCHEMiCAL

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

and the precise role of these proteins in immunoregulation immunophilin

FKBP-12

effort to understand (8). Further linkage FKBP-12

insight

chromosomal

the biological

into the physiological

gene to human chromosome

gene from human-rodent

The human

gene stucture was recently established

role and structure/function

with a human genetic disease.

is uncertain.

functions

relationship

of FKBP-12

of FKBP-12

could come from

In this paper, I report the localization 20 by using PCR to amplify

in an

of the

a region of the

somatic cell hybrids.

MATERIALS

AND METHODS

Oligonucleotides Oligonucleotides were synthesized on an Applied Biosystems DNA Synthesizer. The locations of the oligonucleotides used as PCR primers are shown in Figure 1. PCR primers I (3’-CCGACCCTTCTTCCCCAACGG-5’) and Ill (3’GATCCGTTCGTCCTCCACTAG-5’) are complementary to the sense-strand of exon 3. PCR primers II (5’-TTAGAACCATGGTGAGTGCCC-3’) and IV (5’CTTCCAGTAAAATCAGTFITG-3’) correspond to the sense-strand sequence of intron 2. Cell Lines and DNA Purified genomic DNA samples from a panel of 24 human-hamster cell lines were obtained from the BIOS Corp. (New Haven, CT). The cell lines were derived by fusing a Chinese hamster ovary cell line with peripheral blood leukocytes from human donors (9,lO) and were characterized by karyotype analysis. The chromosome content of the current passage of each somatic hybrid cell was determined by cytogenic analysis of Giemsa banded metaphase spreads and in situ chromosome “painting” using labeled human genomic DNA hybridized to metaphase spreads. Purified genomic DNA samples from a panel of 18 human-rodent somatic cell hybrids were obtained from NIGMS Human Genetic Mutant Cell Repository (Camden, N.J.). Cell lines NA09925 through NA09940 were derived from the fusion of fetal human male fibroblasts (IMR-91) with the thymidine kinase deficient mouse cell line B82 (11 ,12). The hybrid cell line NA10324 was derived in the laboratory of Dr. F. Ruddle (Yale University, New Haven, CT) by the fusion of the human fibroblast cell line GM001 44, with a 46,Xx,-6,+der(6)t(6;21) karyotype, with the HPRT and APRT deficient mouse cell line A9. The hybrid cell line NA10567, resulted from the fusion of the human fibroblast cell line GM02860, with a 46,XY,t(3;16)(ql3.2;ql3) karyotype, with the HPRT and APRT deficient mouse cell line A9 (13). Hybrid cell line NA10611 resulted from the microcell fusion of retroviral vector SP-1 infected human lymphoblast culture GM07890, with a 46,XX,del(13) karyoptype, with the Chinese hamster ovary line UV-135 (14). PCR, Electrophoresis, and Hybridization Analysis PCR was carried out using the nested primer approach as described (15). Reactions (100 pl) using the outside-set primers I and II were carried out in PCR mix (200 pM each dNTP, 10 mM Tris-HCI (pH 8.3), 50 mM KCI, 2 mM MgC12, 1 pM of each primer, and 2.5 units of Taq polymerase) containing loo-250 ng of genomic DNA. PCR amplification was carried out in a DNA thermal cycler (Per-kin-Elmer). The thermal profile consisted of 35 cycles of 95OC for 2 min., 50°C for 2 min., and 72OC for 2.5 min. Following amplification with the outer-set primers, a 2 pl aliquot from each 1428

Vol.

179,

No.

3, 1991

BIOCHEMICAL

AND

BiOPHYSICAL

RESEARCH

COMMUNICATIONS

reaction was then subjected to an additional 35 cycles of amplification in a final volume of lOOpI in PCR mix containing nested primers III and IV. Ten pl of nested primer reactions were electrophoresed on 1% agarose gels, stained with ethidium bromide, and processed for direct- el hybridization as described previously (16). Gel membranes were hybridized to a [32 PI-labeled oligonucleotide probe (3’-GTGTTATCCGACGTCACCGAA-5’) complementary to the sense-strand of intron 2 and specific for the PCR product (Fig. 1A). Gels were hybridized overnight at 37’C in (0.9 M NaCI, 6 mM EDTA, 0.5% SDS, and 0.9 M Tris-HCI, pH 7.5) containing 0.2 mg of salmon sperm DNA and 2x1 O6 cpm of probe per ml of hybridization solution. The gel membranes were then washed twice at O°C for 30 min in TMA (3 M tetramethylammonium chloride (Aldrich), 2 mM EDTA, and 50 mM Tris-HCI, pH 8) once each at 25OC (30 min) and 60°C (7 min) in TMA containing 0.2% SDS, and once at 25OC for 30 min in TMA as described (17). The gel strips were then autoradiographed at -8OOC. RESULTS I designed

PCR primers

of the human FKBP-12 pseudogenes

AND DISCUSSION

that would allow specific amplification

gene in the presence

(8) and the homologous

strategy.

Primers

were designed

12 gene.

The predicted

rodent

gene.

Figure

FKBP-12 1A shows

processed the PCR

from sequences

of intron 2 and exon 3 of the FKBP-

size of the PCR product

was about 1.5 kb. When PCR was

carried out using control human placental detected

of related human

of an intron region

DNA, only the expected

(Fig. 1 B, lane 1). To demonstrate

that the PCR product

1.5 kb fragment was specific

for the

IV-W II-,

H

I PCR product (1.5 kb)

Probe

B

Figure 1, PCR strategy for the amplification of the human FKBP-12 gene. A) The exon-intron organization of the FKBP-12 gene, as previously determined (8), is shown. Exons and introns are denoted by solid boxes and lines, respectively. An exploded view of a region containing the 3’-end of intron 2 and exon 3 is shown below the physical map of the gene; the PCR primer locationsare indicated. Restrictionenzyme abbreviations: B, E&JHI; E, mRI; X, ml; Sm, -1. B) Electrophoretic analysis of the PCR product derived from the intron2/exon3 region of the humanFKBP-12 gene is shown in lane 1. A ml digest of the PCR product is shown in lane 2. M, DNA size markers.

1429

was

Vol.

179,

No.

3, 1991

BIOCHEMICAL

AND

BIOPHYSICAL

RESEARCH

COMMUNICATIONS

1.5-

Figure 2. PCR analysis of human-rodent hybrid panels. Genomic DNA from human, rodent, and the indicated numbered cell lines were amplified by PCR with human FKBP-12 specific oligonucleotide primers. A) Panel I hybrid cell lines from the BIOS Corp. B) Panel II hybrid cell lines from NIGMS. The PCR product was electrophoresed on agarose gels and stained with ethidium bromide (top window of panels I and II). The gels were then hybridized to an oligonucleotide probe specific for the FKBP-12 PCR product (bottom window of panels I and II). “Neg” refers to the negative control (PCR reaction without added DNA). intron2/exon3 restriction

region

enzyme

of the FKBP-12

digestion.

the exon 3 PCR primers ml,

the expected

data indicated

1 .l- and 0.4-kb

on purified

genomic

about 400 bp upstream

detected

of the FKBP-12

of the human FKBP-12 DNA samples

panel I (Fig. 2A).

agarose

gel electrophoresis.

unrelated

human genomic

756) containing

were

analyzed

was digested

by of with

(Fig. 1 B, lane 2). The

gene in the presence

of the

pseudogenes.

localization

cell lines, representing

site is located

fragments

amplification

related human processed

analysis

A unique j@l

was further

(Fig. 1 A). When the 1.5 kb PCR fragment

specific

Chromosomal

gene, the fragment

from 24 individual PCR reaction

The diagnostic DNA controls

human chromosome

gene was determined human-hamster

products

1.5 kb product

were

by PCR hybrid

analyzed

was obtained

by

with three

and only hybrid cell lines (lines 507, 940, and

20 (Fig. 2A, top window). 1430

Hamster

DNA and the

Vol.

BIOCHEMICAL

179, No. 3, 1991

remaining

AND BIOPHYSICAL

hybrid cell lines which do not contain human chromosome

any PCR product.

The data indicated

specific amplification

gene in the presence of rodent chromosomal product

was further

oligonucleotide product hybridized

RESEARCH COMMUNICATIONS

verified

by direct-gel

of the human FKBP-12

DNA. The identity of the FKBP-12 hybridization

DNA control

samples

gene

using a [32P]-labeled

probe specific for intron 2 (Fig. 2A, bottom window).

from the human

20 did not show

The 1.5 kb PCR

and cell lines 507, 940, and 756

to the probe, whereas no hybridization

signal was detected

for hamster

DNA or cell lines that lacked the 1.5 kb band detected on ethidium-stained

gels. The

data suggested

gene with

cosegregation

human chromosome

of the 1.5 kb PCR product of the FKBP-12

20.

TABLE 1 Correlation

of

Gene with &man Chromosomes Somatic Cell Hybrids

F-P-12

in Euman/Rodent

Gene/Chromosome Human

Chromosome

1 2 3 4 5 6 1 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y

+/+

+/-

-/+

-/-

4 5 8 9 11 10 11 9 0 6 6 11 8 13 9 2 11

10

3 2 6 4 20 6 3 9 3 6 4 4 6

25 26 22 24 8 22 25 19 25 22 24 24 22 21 21 24 22 23 20 20 20 24 24 25

8 14 8 9 3 6

9 6 5 3 4 3 5 14 8 8 3 6 1 5 12 3

I 4 6 5 8 0 8 4 4 3

6 0 6 5 11 8

%Discordance 31 26 28 21 55 24 14 33 40 33 28 17 28 19 28 38 21 28 33 0 33 21 36 26

Percent discordance demonstrates the cosegregation of the Note. human FKBP-12 gene with human chromosome 20 by PCR analysis of 42 hybrid cell lines. Percent discordance for each chromosome represents: the presence of the gene in the absence of the chromosome (+/-) plus the absence of the gene in the presence of the chromosome (-/+) divided by the total number of hybrids analyzed, multiplied by presence of the gene/presence of the chromosome. 100. +/+, -I-, absence of the gene/absence of the chromosome.

1431

Vol.

179, No. 3, 1991

The assignment

BIOCHEMICAL

of the FKBP-12

AND BIOPHYSICAL RESEARCH COMMUNICATIONS

gene to human chromosome

20 was further

verified by PCR analysis of DNA samples from a different hybrid panel derived from 18 human-rodent

hybrid cell lines. Figure 28 (panel II) shows detection

1.5 kb PCR product

by ethidium-staining

of the diagnostic

(top window) and hybridization

(bottom

window) for human genomic DNA controls and only hybrid cell lines containing chromosome

20. No PCR product was detected

in panel II for either rodent DNA

samples or hybrid cell lines that lacked human chromosome The results are summarized

20, and 11 to 67% discordance

demonstrated

that the FKBP-12

genetic

disorders,

chromosome

for all other chromosomes.

gene is on human chromosome

and polymorphic

20 (18). Regional

20.

in Table 1. There is 0% discordance

chromosome

DNA markers

mapping

human

The data

20. Several genes,

have been assigned

of the FKBP-12

for human

to human

gene on chromosome

20

may be useful in linkage analysis between FKBP-12 and other human genetic loci.

ACKNOWLEDGMENT

I thank Dr. G. Sathe for the synthesis of oligonucleotide

PCR primers.

REFERENCES 1.

Schreiber,

2.

Fretz, H., Albers, M.W., Galat, A., Standaert, R.F., Lane, W.S., Burakoff, S.J., Bierer, B.E., and Schreiber, S.L. (1991) J. Am. Chem. Sot. 113, 1409-1411. Handschumacher, R.E., Harding, M.W., Rice, J., Drugge, R.J., and Speicher, D.W. (1984) Science 226, 544547. Tocci, M.J., Matkovich, D.A., Collier, K.A., Kwok, P., Dumont, F., Lin, S., Degubicibus, S., Siekierka, J-J., Chin, J., and Hutchinson, N.I. (1989) J. Immunol. 143, 718-729. Dumont, F.J., Staruch, M.J., Koprak, S.L., Melino, M.R., and Sigal, N.H. (1990) J. lmmunol. 144, 251-258. Siekierka, J.J., Weiderrecht, G., Greulich, H., Boulton, D., Hung, H., Cryan, J., and Sigal, N. (1990) J. Biol. Chem. 265, 2101 l-21 015. Koletsky, A., Harding, M., Handschumacher, R. (1986) J. Immunol. 137, 10541059. DiLella, A.G. and Craig, R.J. (1991) Biochemistry 30, 8512-8517. Dana, S. and Wasmuth, J.J. (1982) Somat. Cell Genet. 8, 245-264. Carlock, L.R., Smith, D., and Wasmuth, J. (1986) Somat. Cell Mol. Genet. 12,

3. 4.

5. 6. 7. 8. Q V. 10.

163-l

11. 12. 13.

S.L. (1991) Science 251, 283-287.

74.

Taggart, R.T., Mohandas, T.K., Shows, T.B., and Bell, G.I. (1985) Proc. Natl. Acad. Sci. USA 82, 6240-6244. Mohandas, T., Heinzmann, C., Sparkes. R.S., Wasmuth, J., Edwards, P., and Lusis, A.J. (1986) Somat. Cell Mol. Genet. 12,89-94. Callen, D.F. (1986) Ann. Genet. 29, 235-239. 1432

Vol.

14. 15. 16. 17. 18.

179,

No.

3, 1991

BIOCHEMICAL

AND

BIOPHYSICAL

RESEARCH

COMMUNICATIONS

Warburton, D., Gersen, S., Yti, M.-T., Jackson, C., Handelin, B., and Housman, D. (1990) Genomics 6, 358-366. Mullis, K.B., and Faloona, F.A. (1987) Meth. Enzymol. 155, 335-350. DiLella, A.G., Marvit, J., Lidsky, A.S., Guttler, F., and Woo, S.L.C. (1986) Nature 322, 799-803. DiLella, A.G., and Woo, S.L.C. (1987) Meth. Enzymol. 152, 447-451. McKusick, V.A. (1990) In Genetic Maps (S.J. O’brien, Ed.), Book 5: Human Maps, pp. 5.47-5.114. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

1433